Letters sent to healthcare professionals: Noxafil (posaconazole) tablets and oral suspension not interchangeable -

Letters sent to healthcare professionals: Noxafil (posaconazole) tablets and oral suspension not interchangeable
Information type: Safety alerts
Source: Merck Sharp and Dohme
Specialities: Cancers | Infection and infectious diseases
Summary
MSD has advised healthcare professionals that substitution of the tablets for the oral suspension or vice versa can result in over- or under-dosage. It is therefore advised that prescriptions must specify the dosage form, and pharmacists must ensure correct product is dispensed.
UKMi comment
The European Medicines Agency has previously issued a warning advising that posaconazole (Noxafil) tablets and oral suspension have different doses and are not interchangeable.
Related links: EMA Statement